Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma.

The American journal of surgical pathology - 1 Sept 2016

Khani Francesca, Diolombi Mairo L, Khattar Pallavi, Huang Weihua, Fallon John T, Epstein Jonathan I, Zhong Minghao

Abstract excerpt

Brenner tumors are uncommon ovarian neoplasms, which have morphologic and immunophenotypical features of transitional cell (urothelial) differentiation. The origin of Brenner tumors is perplexing, but they are believed to arise from transitional cell metaplasia occurring within the ovary and/or fallopian tube, although it is controversial whether this metaplasia is truly along transitional cell lines. Recently,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Transitional Cell

Share to Ovarian Neoplasms

Share to Polymerase Chain Reaction

Share to Promoter Regions, Genetic

Share to Telomerase

Share to Urologic Neoplasms

Source

Identifiers

PMID: 27299795
DOI: 10.1097/PAS.0000000000000680

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma.PMID 27299795Read ↗

PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates.Semantic proximity Read ↗

Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.Semantic proximity Read ↗

Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.Semantic proximity Read ↗

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.Semantic proximity Read ↗

Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.Semantic proximity Read ↗

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.Semantic proximity Read ↗

Molecular Characterization of Muellerian Tumors of the Urinary Tract.Semantic proximity Read ↗

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.Semantic proximity Read ↗

Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation.Semantic proximity Read ↗

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.Semantic proximity Read ↗

A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.Semantic proximity Read ↗

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.